Bayer CropScienceBOM:506285 +1.11%80 ROE % is 21.86% as of Mar. 2026, which is 10% above its 10-year median of 19.83. GuruFocus rates BOM:506285 with a GF Score™ of 80/100 and a GF Value™ of ₹5,896.56 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 251 Agriculture companies, Bayer CropScience ranks better than 88.84% on this metric.
The historical rank and industry rank for Bayer CropScience's ROE % or its related term are showing as below:
BOM:506285'
s ROE % Range Over the Past 10 Years
Min: 14.94 Med: 19.83 Max: 28.96
Current: 23.13
During the past 13 years, Bayer CropScience's highest ROE % was 28.96%. The lowest was 14.94%. And the median was 19.83%.
BOM:506285's ROE % is ranked better than 88.84% of 251
companies
in the Agriculture industry
Industry Median: 6.77
vs BOM:506285: 23.13
Bayer CropScience (BOM:506285) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Bayer CropScience ROE % Related Terms
Bayer CropScience ROE % Historical Data
* Premium members only.
The historical data trend for Bayer CropScience's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Bayer CropScience's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayer CropScience ROE % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bayer CropScience's ROE % distribution charts can be found below:
* The bar in red indicates where Bayer CropScience's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Bayer CropScience (BOM:506285) has a ROE % of 21.86% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bayer CropScience and its competitors. This is 10% above median its historical median of 19.83. Over the past decade, Bayer CropScience's ROE % has ranged from 14.94 to 28.96. According to the industry distribution chart, Bayer CropScience ranks #28 out of 251 companies in the Agriculture industry, placing it in the top 11.2%.
Is Bayer CropScience's ROE % too high?
Bayer CropScience's current ROE % of 21.86% is 10% above median its 10-year median of 19.83. Over the past 10 years, this metric has ranged from a low of 14.94 to a high of 28.96. The Agriculture industry median ROE % is 6.77. Bayer CropScience's value of 21.86% is 222.9% above this industry median. Based on the distribution chart, Bayer CropScience ranks #28 out of 251 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Bayer CropScience has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's ROE % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Bayer CropScience ranks #28 out of 251 companies for ROE %. This places Bayer CropScience in the top 11% of its industry — outperforming the majority of peers. The industry median ROE % is 6.77. Bayer CropScience's value of 21.86% is 222.9% above this benchmark. Historically, Bayer CropScience's own ROE % has ranged from 14.94 to 28.96 over the past decade. While the company's 10-year median is 19.83 vs. the industry median of 6.77, Bayer CropScience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Agriculture company?
The median ROE % among Agriculture companies is 6.77, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayer CropScience's current ROE % of 21.86% is 222.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bayer CropScience and its competitors. For the Agriculture industry, the median ROE % is 6.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayer CropScience's current ROE % is 21.86%, which is 10% above median its own 10-year median of 19.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5,896.56, compared to a current price of ₹4,162.70 — trading 29.4% below its estimated fair value. The current ROE % is 21.86%, which is 10% above median its 10-year median of 19.83 and 222.9% above the Agriculture industry median of 6.77. Bayer CropScience's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current ROE % is 21.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer CropScience (BOM:506285) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued.
The current stock price of ₹4,162.70 is trading 29.4% below its estimated GF Value™ of ₹5,896.56.
GuruFocus considers Bayer CropScience to be Modestly Undervalued.
Key valuation signals for BOM:506285:
ROE %: 21.86% (10% above median its 10-year median of 19.83)
GF Value™: ₹5,896.56 vs. price of ₹4,162.70 (29.4% below fair value)
Industry Position: 222.9% above the Agriculture median (#28 of 251)
No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
80GF Score
Get the complete analysis for BOM:506285
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506285 has been successfully added to your 
